Study of a new drug in healthy men
This study is testing how a new drug is processed by the body in healthy men. It will help researchers understand the drug's effects and safety before it is tested in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult male.
- You must be at least 18 years old.
- Your body mass index (BMI) must be between 19 and 26, and you must weigh at least 50 kg.
- You must be willing to give written consent to participate.
- You must not have taken any prescription or over-the-counter medications, herbal remedies, or supplements in the past 30 days.
- You must not have participated in another clinical trial in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how a new drug, called FXS4640, moves through the body in healthy men. It uses a small amount of radioactivity to follow the drug, which helps researchers understand how it is absorbed and cleared. Participation involves staying at the clinic for several days for tests and samples.
This study is for healthy men to see how a new experimental drug moves through the body and leaves it. The drug contains a tiny amount of radiation, which helps researchers track it safely.
This trial tests a new drug called HS-10504 in healthy adults to see how the body processes it. It is an early-phase study that helps determine safe dosing.
This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.
This trial tests whether a new drug is safe in healthy men. It is a ''first-in-human'' study, so it helps determine the right dose and check for side effects.
This study examines how a new drug (called HRS-1780) is processed and eliminated by the body using a special radioactive label. It will help researchers understand the drug’s behavior to guide future studies.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.